Skip to Main Content

Paper Details

In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses.
PLoS One
5
2021
B cell, B cell epitope, MHC-II, MHC-II alleles, RBM B cell epitope, SARS, SARS-CoV, SARS-CoV-2 RBM peptides, SARS-CoV-2 antibodies, T, T cell memory, T-B
Author NameAffiliation
Kivilcim OzturkUniversity of California San Diego
Hannah CarterUniversity of California San Diego
Hannah CarterMoores Cancer Center, University of California San Diego
Hannah CarterUniversity of California San Diego
Hannah CarterMoores Cancer Center, University of California San Diego
  • 1 - 5

Datasets

Release 1.2